Cargando…

Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years

Therapeutic drug monitoring (TDM) is the clinical practice of measuring drug concentrations. TDM can be used to determine treatment efficacy and to prevent the occurrence or reduce the risk of drug-induced side effects, being, thus, a tool of personalized medicine. Drugs for which TDM is applied sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Voulgaridou, Gavriela, Paraskeva, Theodora, Ragia, Georgia, Atzemian, Natalia, Portokallidou, Konstantina, Kolios, George, Arvanitidis, Konstantinos, Manolopoulos, Vangelis G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535589/
https://www.ncbi.nlm.nih.gov/pubmed/37765152
http://dx.doi.org/10.3390/pharmaceutics15092181
_version_ 1785112665461358592
author Voulgaridou, Gavriela
Paraskeva, Theodora
Ragia, Georgia
Atzemian, Natalia
Portokallidou, Konstantina
Kolios, George
Arvanitidis, Konstantinos
Manolopoulos, Vangelis G.
author_facet Voulgaridou, Gavriela
Paraskeva, Theodora
Ragia, Georgia
Atzemian, Natalia
Portokallidou, Konstantina
Kolios, George
Arvanitidis, Konstantinos
Manolopoulos, Vangelis G.
author_sort Voulgaridou, Gavriela
collection PubMed
description Therapeutic drug monitoring (TDM) is the clinical practice of measuring drug concentrations. TDM can be used to determine treatment efficacy and to prevent the occurrence or reduce the risk of drug-induced side effects, being, thus, a tool of personalized medicine. Drugs for which TDM is applied should have a narrow therapeutic range and exhibit both significant pharmacokinetic variability and a predefined target concentration range. The aim of our study was to assess the current status of TDM in Greek public hospitals and estimate its progress over the last 20 years. All Greek public hospitals were contacted to provide data and details on the clinical uptake of TDM in Greece for the years 2003 and 2021 through a structured questionnaire. Data from 113 out of 132 Greek hospitals were collected in 2003, whereas for 2021, we have collected data from 98 out of 122 hospitals. Among these, in 2003 and 2021, 64 and 51 hospitals, respectively, performed TDM. Antiepileptics and antibiotics were the most common drug categories monitored in both years. The total number of drug measurement assays decreased from 2003 to 2021 (153,313 ± 7794 vs. 90,065 ± 5698; p = 0.043). In direct comparisons between hospitals where TDM was performed both in 2003 and 2021 (n = 35), the mean number of measurements was found to decrease for most drugs, including carbamazepine (198.8 ± 46.6 vs. 46.6 ± 10.1, p < 0.001), phenytoin (253.6 ± 59 vs. 120 ± 34.3; p = 0.001), amikacin (147.3 ± 65.2 vs. 91.1 ± 71.4; p = 0.033), digoxin (783.2 ± 226.70 vs. 165.9 ± 28.9; p < 0.001), and theophylline (71.5 ± 28.7 vs. 11.9 ± 6.4; p = 0.004). Only for vancomycin, a significant increase in measurements was recorded (206.1 ± 96.1 vs. 789.1 ± 282.8; p = 0.012). In conclusion, our findings show that TDM clinical implementation is losing ground in Greek hospitals. Efforts and initiatives to reverse this trend are urgently needed.
format Online
Article
Text
id pubmed-10535589
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105355892023-09-29 Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years Voulgaridou, Gavriela Paraskeva, Theodora Ragia, Georgia Atzemian, Natalia Portokallidou, Konstantina Kolios, George Arvanitidis, Konstantinos Manolopoulos, Vangelis G. Pharmaceutics Article Therapeutic drug monitoring (TDM) is the clinical practice of measuring drug concentrations. TDM can be used to determine treatment efficacy and to prevent the occurrence or reduce the risk of drug-induced side effects, being, thus, a tool of personalized medicine. Drugs for which TDM is applied should have a narrow therapeutic range and exhibit both significant pharmacokinetic variability and a predefined target concentration range. The aim of our study was to assess the current status of TDM in Greek public hospitals and estimate its progress over the last 20 years. All Greek public hospitals were contacted to provide data and details on the clinical uptake of TDM in Greece for the years 2003 and 2021 through a structured questionnaire. Data from 113 out of 132 Greek hospitals were collected in 2003, whereas for 2021, we have collected data from 98 out of 122 hospitals. Among these, in 2003 and 2021, 64 and 51 hospitals, respectively, performed TDM. Antiepileptics and antibiotics were the most common drug categories monitored in both years. The total number of drug measurement assays decreased from 2003 to 2021 (153,313 ± 7794 vs. 90,065 ± 5698; p = 0.043). In direct comparisons between hospitals where TDM was performed both in 2003 and 2021 (n = 35), the mean number of measurements was found to decrease for most drugs, including carbamazepine (198.8 ± 46.6 vs. 46.6 ± 10.1, p < 0.001), phenytoin (253.6 ± 59 vs. 120 ± 34.3; p = 0.001), amikacin (147.3 ± 65.2 vs. 91.1 ± 71.4; p = 0.033), digoxin (783.2 ± 226.70 vs. 165.9 ± 28.9; p < 0.001), and theophylline (71.5 ± 28.7 vs. 11.9 ± 6.4; p = 0.004). Only for vancomycin, a significant increase in measurements was recorded (206.1 ± 96.1 vs. 789.1 ± 282.8; p = 0.012). In conclusion, our findings show that TDM clinical implementation is losing ground in Greek hospitals. Efforts and initiatives to reverse this trend are urgently needed. MDPI 2023-08-23 /pmc/articles/PMC10535589/ /pubmed/37765152 http://dx.doi.org/10.3390/pharmaceutics15092181 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Voulgaridou, Gavriela
Paraskeva, Theodora
Ragia, Georgia
Atzemian, Natalia
Portokallidou, Konstantina
Kolios, George
Arvanitidis, Konstantinos
Manolopoulos, Vangelis G.
Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years
title Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years
title_full Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years
title_fullStr Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years
title_full_unstemmed Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years
title_short Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years
title_sort therapeutic drug monitoring (tdm) implementation in public hospitals in greece in 2003 and 2021: a comparative analysis of tdm evolution over the years
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535589/
https://www.ncbi.nlm.nih.gov/pubmed/37765152
http://dx.doi.org/10.3390/pharmaceutics15092181
work_keys_str_mv AT voulgaridougavriela therapeuticdrugmonitoringtdmimplementationinpublichospitalsingreecein2003and2021acomparativeanalysisoftdmevolutionovertheyears
AT paraskevatheodora therapeuticdrugmonitoringtdmimplementationinpublichospitalsingreecein2003and2021acomparativeanalysisoftdmevolutionovertheyears
AT ragiageorgia therapeuticdrugmonitoringtdmimplementationinpublichospitalsingreecein2003and2021acomparativeanalysisoftdmevolutionovertheyears
AT atzemiannatalia therapeuticdrugmonitoringtdmimplementationinpublichospitalsingreecein2003and2021acomparativeanalysisoftdmevolutionovertheyears
AT portokallidoukonstantina therapeuticdrugmonitoringtdmimplementationinpublichospitalsingreecein2003and2021acomparativeanalysisoftdmevolutionovertheyears
AT koliosgeorge therapeuticdrugmonitoringtdmimplementationinpublichospitalsingreecein2003and2021acomparativeanalysisoftdmevolutionovertheyears
AT arvanitidiskonstantinos therapeuticdrugmonitoringtdmimplementationinpublichospitalsingreecein2003and2021acomparativeanalysisoftdmevolutionovertheyears
AT manolopoulosvangelisg therapeuticdrugmonitoringtdmimplementationinpublichospitalsingreecein2003and2021acomparativeanalysisoftdmevolutionovertheyears